ADVFN - Advanced Financial Network.
HOME» NASDAQ » I » ILMN Stock Price » ILMN Stock News

Illumina Share News

 Illumina (mm) Stock Price
ILMN Stock Price
 Illumina (mm) Stock Chart
ILMN Stock Chart
 Illumina (mm) Stock News
ILMN Stock News
 Illumina (mm) Company Information
ILMN Company Information
 Illumina (mm) Stock Trades
ILMN Stock Trades

Roche: FTC Requests More Information On Illumina Offer

DOW JONES NEWSWIRES U.S. regulators have asked Roche Holding AG (ROG.VX, RHHBY) for additional information about its proposed takeover of Illumina Inc. (ILMN), the drug maker said Tuesday. The Federal Trade Commission's request reflects antitrust concerns about Roche's microarray business and would delay any acquisition another 10 days after Roche complies with the second request under U.S. law. Roche is still working to complete its hostile takeover of Illumina, which continues to oppose the Swiss company's offer as inadequate. Illumina makes machines that use blood or tissue samples to decode a person's entire genetic makeup in about a week--a process known as DNA sequencing. Shares of the takeover target closed at $50.34 Tuesday and were unchanged after hours. Roche's cash offer values the company at $44.50 a share. -By Drew FitzGerald, Dow Jones Newswires; 212-416-2909;

Stock News for Illumina (ILMN)
07/24/201519:36:07Statement of Changes in Beneficial Ownership (4)
07/24/201519:20:27Statement of Changes in Beneficial Ownership (4)
07/22/201508:31:44Current Report Filing (8-k)
07/21/201516:09:00Current Report Filing (8-k)
07/21/201516:05:00Illumina Reports Financial Results for Second Quarter of Fiscal...
07/20/201516:05:00Illumina Names Sanjay Chikarmane as Senior Vice President and...
07/17/201518:30:53Statement of Changes in Beneficial Ownership (4)
07/17/201517:21:19Statement of Changes in Beneficial Ownership (4)
07/16/201518:45:31Statement of Changes in Beneficial Ownership (4)
07/16/201518:31:26Statement of Changes in Beneficial Ownership (4)
07/16/201506:30:00Illumina Introduces Illumina SeqLab
07/15/201516:04:02Amended Annual Report (10-k/a)
07/13/201516:05:00Study of Illumina’s Non-Invasive verifi® Prenatal Test Suggests th...
07/10/201516:48:22Amended Statement of Changes in Beneficial Ownership (4/a)
07/07/201518:11:10Statement of Changes in Beneficial Ownership (4)
07/07/201514:04:49Statement of Changes in Beneficial Ownership (4)
07/07/201508:45:00Neogen signs commercialization agreement with Illumina
07/07/201506:30:00Illumina to Announce Second Quarter 2015 Financial Results on...
07/01/201518:32:49Statement of Changes in Beneficial Ownership (4)
07/01/201518:26:54Statement of Changes in Beneficial Ownership (4)

Illumina and other NASDAQ stock quotes are delayed by at least 20 minutes.
All other stock price and quote data is delayed by at least 15 minutes unless otherwise stated. By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Contact Us | Copyright 1999-2007 ADVFN PLC. | Privacy Policy | Investment Warning | Data accreditations | Investor Relations